日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Towards Complete Tumor Resection: Novel Dual-Modality Probes for Improved Image-Guided Surgery of GRPR-Expressing Prostate Cancer

迈向肿瘤完全切除：新型双模态探针用于改进GRPR表达前列腺癌的图像引导手术

期刊:Pharmaceutics
影响因子:5.5
doi:10.3390/pharmaceutics14010195
Handula, Maryana; Verhoeven, Marjolein; Chen, Kuo-Ting; Haeck, Joost; de Jong, Marion; Dalm, Simone U; Seimbille, Yann
肿瘤
前列腺癌
肿瘤免疫
发表日期：2022
文献求助 收藏

Does the proteasome inhibitor bortezomib sensitize to DNA-damaging therapy in gastroenteropancreatic neuroendocrine neoplasms? - A preclinical assessment in vitro and in vivo.

蛋白酶体抑制剂硼替佐米能否增强胃肠胰神经内分泌肿瘤对DNA损伤疗法的敏感性？——体外和体内临床前评估

期刊:Neoplasia
影响因子:7.7
doi:10.1016/j.neo.2020.11.004
Briest Franziska, Koziolek Eva J, Albrecht Jakob, Schmidt Fränze, Bernsen Monique R, Haeck Joost, Kühl Anja A, Sedding Dagmar, Hartung Teresa, Exner Samantha, Welzel Martina, Fischer Christian, Grötzinger Carsten, Brenner Winfried, Baum Richard P, Grabowski Patricia
肿瘤
发表日期：2021
文献求助 收藏

Theranostic Design of Angiopep-2 Conjugated Hyaluronic Acid Nanoparticles (Thera-ANG-cHANPs) for Dual Targeting and Boosted Imaging of Glioma Cells

用于胶质瘤细胞双重靶向和增强成像的Angiopep-2偶联透明质酸纳米颗粒（Thera-ANG-cHANPs）的诊疗一体化设计

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers13030503
Costagliola di Polidoro, Angela; Zambito, Giorgia; Haeck, Joost; Mezzanotte, Laura; Lamfers, Martine; Netti, Paolo Antonio; Torino, Enza
胶质瘤
细胞生物学
发表日期：2021
文献求助 收藏

In Vivo Evaluation of Gallium-68-Labeled IRDye800CW as a Necrosis Avid Contrast Agent in Solid Tumors

镓-68标记的IRDye800CW作为实体瘤坏死亲和对比剂的体内评价

期刊:Contrast Media & Molecular Imaging
影响因子:
doi:10.1155/2021/2853522
Stroet, Marcus C M; de Blois, Erik; Haeck, Joost; Seimbille, Yann; Mezzanotte, Laura; de Jong, Marion; Löwik, Clemens W G M; Panth, Kranthi M
发表日期：2021
文献求助 收藏

In Vivo Evaluation of Indium-111-Labeled 800CW as a Necrosis-Avid Contrast Agent

体内评价铟-111标记的800CW作为坏死亲和性造影剂

期刊:Molecular Imaging and Biology
影响因子:2.5
doi:10.1007/s11307-020-01511-x
Stroet, Marcus C M; de Blois, Erik; Stuurman, Debra C; de Ridder, Corrina M A; Haeck, Joost; Seimbille, Yann; Mezzanotte, Laura; de Jong, Marion; Löwik, Clemens W G M; Panth, Kranthi M
发表日期：2020
文献求助 收藏

Preclinical Efficacy and Safety Evaluation of Hematopoietic Stem Cell Gene Therapy in a Mouse Model of MNGIE

在MNGIE小鼠模型中，造血干细胞基因疗法的临床前疗效和安全性评价

期刊:Molecular Therapy-Methods & Clinical Development
影响因子:4.7
doi:10.1016/j.omtm.2018.01.001
Yadak, Rana; Cabrera-Pérez, Raquel; Torres-Torronteras, Javier; Bugiani, Marianna; Haeck, Joost C; Huston, Marshall W; Bogaerts, Elly; Goffart, Steffi; Jacobs, Edwin H; Stok, Merel; Leonardelli, Lorena; Biasco, Luca; Verdijk, Robert M; Bernsen, Monique R; Ruijter, George; Martí, Ramon; Wagemaker, Gerard; van Til, Niek P; de Coo, Irenaeus F M
细胞生物学
发育与干细胞
Mouse
干细胞
发表日期：2018
文献求助 收藏

In Vivo Stabilized SB3, an Attractive GRPR Antagonist, for Pre- and Intra-Operative Imaging for Prostate Cancer

体内稳定的SB3是一种有吸引力的GRPR拮抗剂，可用于前列腺癌的术前和术中成像

期刊:Molecular Imaging and Biology
影响因子:2.5
doi:10.1007/s11307-018-1185-z
Bakker, Ingrid L; van Tiel, Sandra T; Haeck, Joost; Doeswijk, Gabriela N; de Blois, Erik; Segbers, Marcel; Maina, Theodosia; Nock, Berthold A; de Jong, Marion; Dalm, Simone U
肿瘤
前列腺癌
肿瘤免疫
发表日期：2018
文献求助 收藏

Optimization of combined temozolomide and peptide receptor radionuclide therapy (PRRT) in mice after multimodality molecular imaging studies

多模态分子影像学研究后，优化小鼠联合替莫唑胺和肽受体放射性核素治疗（PRRT）方案

期刊:Ejnmmi Research
影响因子:3
doi:10.1186/s13550-015-0142-y
Bison, Sander M; Haeck, Joost C; Bol, K; Koelewijn, S J; Groen, H C; Melis, M; Veenland, J F; Bernsen, M R; de Jong, M
信号转导
发表日期：2015
文献求助 收藏

Can DCE-MRI explain the heterogeneity in radiopeptide uptake imaged by SPECT in a pancreatic neuroendocrine tumor model?

DCE-MRI能否解释SPECT成像在胰腺神经内分泌肿瘤模型中放射性肽摄取的异质性？

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0077076
Bol, Karin; Haeck, Joost C; Groen, Harald C; Niessen, Wiro J; Bernsen, Monique R; de Jong, Marion; Veenland, Jifke F
肿瘤
肿瘤免疫
发表日期：2013
文献求助 收藏